二米瑞/蛋白皮克林乳液:界面行为,风病学,以及体外生物可访问性
Shengqi Mei1,2, Lei Dou1,2, Kaixuan Cheng1,2
1College of Biological and Food Engineering, Hubei Minzu University, Enshi 445000, China.
Foods (Basel, Switzerland)
|July 29, 2025
概括
狄米瑞 (DHM) 和大豆蛋白分离物 (SPI) 为皮克林乳液形成复合物,增强DHM的输送和生物可访问性. 这个系统有效地提供DHM,减缓脂质氧化,并显示出生物活性应用的潜力.
科学领域:
- 食品科学与技术 食品科学与技术
- 生物材料工程 生物材料工程
- 营养药物输送系统 营养药物输送系统
背景情况:
- 蛋白质多复合物是封装生物活性化合物的关键,提高溶解度和生物可用性.
- 二米瑞 (DHM) 是一种具有潜在健康益处的生物活性化合物.
- 豆蛋白分离物 (SPI) 是一种广泛可用的功能性食品成分.
研究的目的:
- 开发和描述用于皮克林乳液形成的二米瑞/大豆蛋白分离物 (DHM/SPI) 复合物.
- 评估DHM/SPI皮克林乳液作为DHM的输送系统.
- 评估DHM在开发的乳液中的稳定性,结构性质和生物可访问性.
主要方法:
- 通过键形成DHM/SPI复合物的形成.
- 使用DHM/SPI复合物作为乳化剂制备皮克林乳液.
- 乳液滴滴大小的表征,乳液类型 (CLSM) 和质性质.
- 通过体外模拟消化对DHM生物可访问性的评估.
- 评估DHM对乳液内的脂质氧化的影响.
主要成果:
- 形成负电荷的DHM/SPI复合体,随着DHM的增加而稳定.
- 乳液滴滴大小受到DHM度,颗粒度,离子强度和油相度的影响.
- 同焦激光扫描显微镜 (CLSM) 证实了油在水乳液结构.
- 皮克林乳液表现出弹性,凝状网络和非牛顿行为.
- 加入DHM降低了脂质氧化,而体外生物可访问性达到33.51%.
结论:
- DHM/SPI复合物有效地稳定了用于DHM输送的皮克林乳液.
- 开发的乳液系统增强了DHM的稳定性和生物可访问性.
- 该系统有望提供DHM并利用其相关的生物活性效应.
相关概念视频
01:20Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
267
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
267
01:23Membrane Fluidity
156.5K
Cell membranes are composed of phospholipids, proteins, and carbohydrates loosely attached to one another through chemical interactions. Molecules are generally able to move about in the plane of the membrane, giving the membrane its flexible nature called fluidity. Two other features of the membrane contribute to membrane fluidity: the chemical structure of the phospholipids and the presence of cholesterol in the membrane.
156.5K